NCT00559468View on ClinicalTrials.gov

Sugammadex After Continuous Infusion of Rocuronium During Sevoflurane and Propofol Anesthesia (P05949; MK-8616-028)

PHASE3CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

December 7, 2006

Primary Completion Date

March 2, 2007

Study Completion Date

March 2, 2007

Conditions
Anesthesia, General
Interventions
DRUG

Sugammadex

Single dose 4.0 mg/kg sugammadex, administered at T1 3-10% after continuous infusion of rocuronium

DRUG

Rocuronium

Single bolus dose 0.6 mg/kg rocuronium and continuous infusion rocuronium

DRUG

Sevoflurane

Sevoflurane IV administered for induction and maintenance of anesthesia, based on randomization.

DRUG

Propofol

Propofol IV administered for induction and maintenance of anesthesia, based on randomization.

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00559468 - Sugammadex After Continuous Infusion of Rocuronium During Sevoflurane and Propofol Anesthesia (P05949; MK-8616-028) | Biotech Hunter | Biotech Hunter